CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale President and CEO sold 5,241 shares at $9.13 ($47,845)
- 4 Open-market sale Chief Accounting Officer sold 2,414 shares at $9.13 ($22,036)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Exhibits
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 313,446 shares at $10.10 ($3,165,021)
- 4 Open-market buy 10% owner bought 507,407 shares at $9.35 ($4,744,255)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
Page 2 of 57 · 1,133 filings